[KR-바이오] 09/24 Korea Market Insights
삼성바이오로직스악재 As a senior equity analyst, the recent announcement of a massive (3 trillion KRW rights offering) has triggered immediate market anxiety, leading to a sharp (7% drop in share price) as investors digest potential (dilution risks). While the company…